Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston polyolefins/chemicals (NYSE: LYB) ~$40B revenue; 10M metric ton polyolefins, MoReTec molecular recycling, refinery closure for core focus, CDP climate A score competing with Dow Chemical and SABIC.
LyondellBasell Industries N.V. is a Houston, Texas-based global polyolefins and chemicals company — publicly traded on the New York Stock Exchange (NYSE: LYB) as an S&P 500 Materials component — manufacturing polypropylene, polyethylene, propylene oxide, styrenic polymers, and specialty chemical compounds used in plastics for packaging, automotive parts, pipes, and consumer products through approximately 29,000 employees in 100 manufacturing sites across 22 countries. LyondellBasell is one of the world's largest plastics, chemicals, and refining companies, producing approximately 10 million metric tons of polyolefins annually — polyethylene and polypropylene that are the input materials for the plastic packaging, consumer goods containers, automotive components, and construction materials that the global economy requires. In 2024, LyondellBasell published its sustainability report with an improved CDP climate change score of A (up from A-) and progress toward sourcing 50% of electricity from renewable sources by 2030. CEO Peter Vanacker has led the company's strategic repositioning toward higher-margin specialty chemicals, circular economy plastics recycling, and portfolio optimization — including the announced closure of the Houston refinery (one of the largest US refinery closures in recent years) to focus on core polyolefins and chemicals, and the development of molecular recycling technology for post-consumer plastic waste through the MoReTec advanced recycling program.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.